These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 31365327)

  • 1. There's Much Yet to be Done: Diverse Perspectives on HPV Vaccination.
    Zimet GD; Osazuwa-Peters N
    Hum Vaccin Immunother; 2019; 15(7-8):1459-1464. PubMed ID: 31365327
    [No Abstract]   [Full Text] [Related]  

  • 2. Human Papillomavirus (HPV) Vaccination Coverage among Rhode Island Adolescents, 2008-2016.
    Kim HH; Washburn T; Marceau K; Duggan-Ball S; Raymond P
    R I Med J (2013); 2018 Mar; 101(2):49-51. PubMed ID: 29490327
    [No Abstract]   [Full Text] [Related]  

  • 3. Excess Cancer Cases and Medical Costs Due to Suboptimal Human Papillomavirus Vaccination Coverage in California.
    Baughan EB; Keizur EM; Damico CA; Arnold EM; Ko JS; Klausner JD
    Sex Transm Dis; 2019 Aug; 46(8):527-531. PubMed ID: 31295221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On surmounting the barriers to HPV vaccination: we can do better.
    Attia AC; Wolf J; Núñez AE
    Ann Med; 2018 May; 50(3):209-225. PubMed ID: 29316825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interventions to increase HPV vaccination coverage: A systematic review.
    Smulian EA; Mitchell KR; Stokley S
    Hum Vaccin Immunother; 2016 Jun; 12(6):1566-88. PubMed ID: 26838959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety of HPV vaccines in the age of nonavalent vaccination.
    Quattrone F; Canale A; Filippetti E; Tulipani A; Porretta A; Lopalco PL
    Minerva Pediatr; 2018 Feb; 70(1):59-66. PubMed ID: 29363293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiological dynamic modeling of human papillomavirus-related diseases to assess vaccination strategies in Argentina.
    Borracci RA; Segal SV; Méndez JH
    Medicina (B Aires); 2018; 78(5):315-328. PubMed ID: 30285924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increases in Human Papillomavirus Vaccination Among Adolescent and Young Adult Males in the United States, 2011-2016.
    Patel EU; Grabowski MK; Eisenberg AL; Packman ZR; Gravitt PE; Tobian AAR
    J Infect Dis; 2018 Jun; 218(1):109-113. PubMed ID: 29584878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, controlled, pragmatic trial of an iPad-based, tailored messaging intervention to increase human papillomavirus vaccination among Latinos.
    Dempsey AF; Maertens J; Sevick C; Jimenez-Zambrano A; Juarez-Colunga E
    Hum Vaccin Immunother; 2019; 15(7-8):1577-1584. PubMed ID: 30689494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of HPV vaccination: Achievements and future challenges.
    Brotherton JML
    Papillomavirus Res; 2019 Jun; 7():138-140. PubMed ID: 30978413
    [No Abstract]   [Full Text] [Related]  

  • 11. Human papillomavirus (HPV) vaccine coverage achievements in low and middle-income countries 2007-2016.
    Gallagher KE; Howard N; Kabakama S; Mounier-Jack S; Burchett HED; LaMontagne DS; Watson-Jones D
    Papillomavirus Res; 2017 Dec; 4():72-78. PubMed ID: 29179873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extended coverage of HPV vaccination in middle-aged adults to prevent oropharyngeal cancers.
    Arya SC; Agarwal N
    Hum Vaccin Immunother; 2012 Jul; 8(7):959. PubMed ID: 22777098
    [No Abstract]   [Full Text] [Related]  

  • 13. Strengthening the Effectiveness of National, State, and Local Efforts to Improve HPV Vaccination Coverage in the United States: Recommendations From the National Vaccine Advisory Committee.
    Approved by the National Vaccine Advisory Committee on June 25, 2018
    Public Health Rep; 2018; 133(5):543-550. PubMed ID: 30091942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HPV: Cameroon fights back against one of the world's lowest vaccination rates.
    Ferguson S
    BMJ; 2024 Jul; 386():q607. PubMed ID: 38950963
    [No Abstract]   [Full Text] [Related]  

  • 15. Increasing HPV Vaccination Coverage Through Provider-Based Interventions.
    Krantz L; Ollberding NJ; Beck AF; Carol Burkhardt M
    Clin Pediatr (Phila); 2018 Mar; 57(3):319-326. PubMed ID: 28750550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding the use of digital technology to promote human papillomavirus vaccination - A RE-AIM framework approach.
    Stephens AB; Wynn CS; Stockwell MS
    Hum Vaccin Immunother; 2019; 15(7-8):1549-1561. PubMed ID: 31158064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HPV vaccine coverage in Australia and associations with HPV vaccine information exposure among Australian Twitter users.
    Dyda A; Shah Z; Surian D; Martin P; Coiera E; Dey A; Leask J; Dunn AG
    Hum Vaccin Immunother; 2019; 15(7-8):1488-1495. PubMed ID: 30978147
    [No Abstract]   [Full Text] [Related]  

  • 18. Engaging parents around vaccine confidence: proceedings from the National HPV Vaccination Roundtable meetings.
    Perkins RB; Fisher-Borne M; Brewer NT
    Hum Vaccin Immunother; 2019; 15(7-8):1639-1640. PubMed ID: 30188782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human papillomavirus vaccine update.
    Gilmer LS
    Prim Care; 2015 Mar; 42(1):17-32. PubMed ID: 25634702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring variation in human papillomavirus vaccination uptake in Switzerland: a multilevel spatial analysis of a national vaccination coverage survey.
    Riesen M; Konstantinoudis G; Lang P; Low N; Hatz C; Maeusezahl M; Spaar A; Bühlmann M; Spycher BD; Althaus CL
    BMJ Open; 2018 May; 8(5):e021006. PubMed ID: 29773702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.